Crossmark

Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application

Crossref DOI link: https://doi.org/10.1007/s43440-024-00663-9

Published Online: 2024-10-10

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kocur, Arkadiusz https://orcid.org/0000-0002-4833-8532
Czajkowska, Agnieszka https://orcid.org/0000-0003-0199-5751
Rębis, Kamila

Rubik, Jacek https://orcid.org/0000-0002-3392-2154
Moczulski, Mateusz https://orcid.org/0000-0003-3770-2762
Kot, Bartłomiej

Sierakowski, Maciej

Pawiński, Tomasz https://orcid.org/0000-0001-9110-4312
Funding

Funding for this research was provided by:

Warszawski Uniwersytet Medyczny (1/F/MB/N/24)

Instytut Pomnik - Centrum Zdrowia Dziecka (S198/2022)
License Information

Text and Data Mining valid from 2024-10-10

Version of Record valid from 2024-10-10
More Information

Article History

Received: 11 August 2024

Revised: 26 September 2024

Accepted: 1 October 2024

First Online: 10 October 2024

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and the International Council for Harmonization Guidance for Good Clinical Practice. The Bioethics Committee of the Children’s Memorial Health Institute in Warsaw approved this project (number of agreements: 15/KBE/2023, with later amendments).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below